Discussions around diversity, equity, and inclusion (DEI) in clinical trials have become increasingly central in drug development. Despite this evolution, there remain gaps in understanding about where accessibility fits within DEI strategies and initiatives.
These gaps present a significant challenge to research in general, but particularly in rare diseases where patient populations are much smaller and margins for error narrow. With these constraints in mind, inclusive trial design is essential, and accessibility can often become a critical success factor.
In this series, attendees will learn about:
- Myriad types of accessibility considerations for rare disease clinical research
- How accessibility considerations fit into DEI plans
- Best practices in accessible clinical trial design and implementation
Each panel, whether watched individually or in totality with the other panels, will provide insights into the value of accessibility in rare disease clinical research and how sponsors, patient advocates, researchers and regulators might move from discussion to action.
Individual panel discussions
March 27, 2023
March 28, 2023
March 29, 2023
March 30, 2023
ASL translation and closed captioning were provided (English) for the live event.
All registered attendees will be emailed a link to:
- Video recordings
- Subtitled video recording and full transcripts in the following languages are in process. Registered attendees will receive a link to the translations when available.
All translation services provided courtesy of ICON Language Services.